MicroPort Endovascular MedTech Ltd (688016) - Total Liabilities

Latest as of December 2025: CN¥-3.98 Billion CNY ≈ $-582.73 Million USD

Based on the latest financial reports, MicroPort Endovascular MedTech Ltd (688016) has total liabilities worth CN¥-3.98 Billion CNY (≈ $-582.73 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688016 cash flow conversion to assess how effectively this company generates cash.

MicroPort Endovascular MedTech Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how MicroPort Endovascular MedTech Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of MicroPort Endovascular MedTech Ltd to evaluate the company's liquid asset resilience ratio.

MicroPort Endovascular MedTech Ltd Competitors by Total Liabilities

The table below lists competitors of MicroPort Endovascular MedTech Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Mednax Inc NYSE:MD	USA	$1.31 Billion
Beijing Yuanliu Hongyuan Electronic Technology Co Ltd SHG:603267	China	CN¥1.02 Billion
Pharvaris BV NASDAQ:PHVS	USA	$26.66 Million
DANAOS CORP. DL -01 F:DVW1	Germany	€1.32 Billion
Capricor Therapeutics Inc NASDAQ:CAPR	USA	$50.16 Million
TPV Technology Co Ltd SHE:000727	China	CN¥29.22 Billion
Beach Energy Ltd AU:BPT	Australia	AU$2.25 Billion
Poly Medicure Limited NSE:POLYMED	India	Rs6.55 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down MicroPort Endovascular MedTech Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MicroPort Endovascular MedTech Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	-0.86	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MicroPort Endovascular MedTech Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MicroPort Endovascular MedTech Ltd (2016–2025)

The table below shows the annual total liabilities of MicroPort Endovascular MedTech Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥-3.98 Billion ≈ $-582.73 Million	-948.88%
2024-12-31	CN¥469.13 Million ≈ $68.65 Million	+22.60%
2023-12-31	CN¥382.63 Million ≈ $55.99 Million	+51.54%
2022-12-31	CN¥252.49 Million ≈ $36.95 Million	+9.08%
2021-12-31	CN¥231.47 Million ≈ $33.87 Million	+62.90%
2020-12-31	CN¥142.09 Million ≈ $20.79 Million	+58.34%
2019-12-31	CN¥89.74 Million ≈ $13.13 Million	+70.41%
2018-12-31	CN¥52.66 Million ≈ $7.71 Million	+45.29%
2017-12-31	CN¥36.24 Million ≈ $5.30 Million	-44.43%
2016-12-31	CN¥65.22 Million ≈ $9.54 Million	--

About MicroPort Endovascular MedTech Ltd

SHG:688016 China Medical Devices

Market Cap

$1.82 Billion

CN¥12.42 Billion CNY

Market Cap Rank

#6665 Global

#1540 in China

Share Price

CN¥100.79

Change (1 day)

-1.50%

52-Week Range

CN¥85.06 - CN¥121.45

All Time High

CN¥443.37